Trial Information

Summary: Hypertension Study CLCI699A2201

Novartis is conducting this clinical research study is to find out if the study drug LCI699 is safe, tolerable, and helps to lower blood pressure in participants who have mild to moderate hypertension (high blood pressure). Participants must be between 18 and 75 years old. The study drug LCI699 is considered investigational which means that it is still being tested and is not approved by the Health Authorities.

Participants will be required to visit the study center 8 times over a 13 week period.
For more information about this clinical trial, visit www.NovartisClinicalTrials.com

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: November 21, 2008 at 2:56:23 PM